On March 9, 2020, Eric Curtis was appointed Senior Vice President and Chief Operating Officer (COO) of Windtree Therapeutics, Inc. Mr. Curtis, age 52, has served as the Chief Executive Officer and President of Centurion Biopharma Corp. and President and Chief Operating Officer of CytRX Corporation, since February 2018. Prior to joining Centurion, from May 2016 to January 2018, Mr. Curtis served as Principal of Curtis Biopharm Consulting, where he provided strategic consultancy services to a variety of healthcare-focused companies, including the Company. From November 2014 to May 2016, Mr. Curtis held the position of President, US Commercial at Aegerion Pharmaceuticals.